Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial

Paul H. Lysaker,Peter J. Weiden,Xiaowu Sun,Amy K. O’Sullivan,Joseph P. McEvoy
DOI: https://doi.org/10.1186/s12888-022-04190-w
IF: 4.144
2022-08-29
BMC Psychiatry
Abstract:Impaired insight poses a challenge in the treatment of patients with schizophrenia because of its potential to jeopardize therapeutic engagement and medication adherence. This study explored how insight impairment, graded from none to extreme, is related to patient-reported mental health status, depression, and neurocognition in schizophrenia.
psychiatry
What problem does this paper attempt to address?